Gratus Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $591K | Sell |
7,507
-287
| -4% | -$23.5K | 0.02% | 233 |
|
|
2024
Q1 | $679K | Buy |
7,794
+4,563
| +141% | +$389K | 0.03% | 201 |
|
|
2023
Q4 | $266K | Sell |
3,231
-806
| -20% | -$61.4K | 0.02% | 230 |
|
|
2023
Q3 | $316K | Buy |
4,037
+324
| +9% | +$27.1K | 0.02% | 206 |
|
|
2023
Q2 | $327K | Buy |
3,713
+173
| +5% | +$14.9K | 0.02% | 202 |
|
|
2023
Q1 | $285K | Buy |
3,540
+379
| +12% | +$30.9K | 0.02% | 192 |
|
|
2022
Q4 | $246K | Sell |
3,161
-1,186
| -27% | -$96.1K | 0.02% | 208 |
|
|
2022
Q3 | $351K | Buy |
4,347
+579
| +15% | +$52K | 0.04% | 164 |
|
|
2022
Q2 | $338K | Buy |
3,768
+41
| +1% | +$4.15K | 0.04% | 153 |
|
|
2022
Q1 | $414K | Sell |
3,727
-87,138
| -96% | -$9.21M | 0.04% | 155 |
|
|
2021
Q4 | $9.4M | Buy |
90,865
+3,402
| +4% | +$394K | 0.87% | 43 |
|
|
2021
Q3 | $11M | Buy |
87,463
+3,485
| +4% | +$451K | 1.18% | 28 |
|
|
2021
Q2 | $10.4M | Buy |
83,978
+7,436
| +10% | +$934K | 1.16% | 33 |
|
|
2021
Q1 | $9.04M | Buy |
76,542
+4,398
| +6% | +$515K | 1.09% | 36 |
|
|
2020
Q4 | $8.45M | Buy |
72,144
+4,456
| +7% | +$491K | 1.13% | 35 |
|
|
2020
Q3 | $7.03M | Buy |
67,688
+2,718
| +4% | +$273K | 1.1% | 35 |
|
|
2020
Q2 | $5.96M | Sell |
64,970
-20,810
| -24% | -$2M | 1% | 46 |
|
|
2020
Q1 | $7.74M | Sell |
85,780
-10,292
| -11% | -$1.09M | 1.44% | 18 |
|
|
2019
Q4 | $10.9M | Buy |
96,072
+1,042
| +1% | +$114K | 1.66% | 13 |
|
|
2019
Q3 | $10.3M | Sell |
95,030
-130
| -0.1% | -$13.6K | 1.68% | 12 |
|
|
2019
Q2 | $9.27M | Buy |
95,160
+11,757
| +14% | +$1.07M | 1.51% | 15 |
|
|
2019
Q1 | $7.6M | Buy |
83,403
+3,793
| +5% | +$339K | 1.27% | 26 |
|
|
2018
Q4 | $7.24M | Buy |
79,610
+2,749
| +4% | +$257K | 1.49% | 19 |
|
|
2018
Q3 | $7.56M | Buy |
76,861
+2,620
| +4% | +$242K | 1.04% | 22 |
|
|
2018
Q2 | $6.36M | Buy |
74,241
+1,642
| +2% | +$137K | 0.94% | 25 |
|
|
2018
Q1 | $5.82M | Sell |
72,599
-16,306
| -18% | -$1.34M | 0.84% | 28 |
|
|
2017
Q4 | $7.18M | Buy |
88,905
+10,613
| +14% | +$850K | 0.93% | 28 |
|
|
2017
Q3 | $6.09M | Buy |
78,292
+4,892
| +7% | +$406K | 0.85% | 30 |
|
|
2017
Q2 | $6.51M | Buy |
73,400
+2,744
| +4% | +$231K | 0.93% | 26 |
|
|
2017
Q1 | $5.69M | Buy |
70,656
+5,199
| +8% | +$406K | 0.82% | 35 |
|
|
2016
Q4 | $4.66M | Buy |
65,457
+658
| +1% | +$51.7K | 0.7% | 42 |
|
|
2016
Q3 | $5.6M | Buy |
64,799
+685
| +1% | +$59.7K | 0.82% | 34 |
|
|
2016
Q2 | $5.56M | Sell |
64,114
-27,394
| -30% | -$2.22M | 0.82% | 33 |
|
|
2016
Q1 | $6.86M | Buy |
91,508
+10,489
| +13% | +$790K | 1.5% | 16 |
|
|
2015
Q4 | $6.23M | Buy |
81,019
+14,686
| +22% | +$1.11M | 1.42% | 11 |
|
|
2015
Q3 | $4.44M | Sell |
66,333
-560
| -0.8% | -$41.2K | 1.07% | 23 |
|
|
2015
Q2 | $4.96M | Sell |
66,893
-18
| -0% | -$1.38K | 1.16% | 22 |
|
|
2015
Q1 | $5.22M | Buy |
+66,911
| New | +$5.07M | 1.16% | 21 |
|
Other funds holding MDT
Gratus Capital's MDT Position: Q2 2024 in Review
Gratus Capital reduced its Medtronic (MDT) stake by 3.7% in Q2 2024, selling an estimated $23.5K and leaving 7,507 shares worth $591K. The position accounts for 0.02% of the portfolio, ranked #233.
Gratus Capital first reported a position in MDT in Q1 2015 and has held it in 38 quarters since. The position peaked at $11M in Q3 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2024.
- Gratus Capital held 7,507 shares of Medtronic worth $591K as of Q2 2024.
- Gratus Capital sold 287 Medtronic shares in Q2 2024, an estimated $23.5K.
- Medtronic made up 0.02% of Gratus Capital's portfolio in Q2 2024, its #233 holding.
- Gratus Capital first reported a position in Medtronic in Q1 2015 and has held it in 38 quarters since.
- Gratus Capital's Medtronic position peaked at $11M in Q3 2021.
- 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.
Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.